Author:
Mbita Zukile,Miya Thabiso Victor,Ramagoma Rolivhuwa Bishop,Jeyapalan Jennie N.,Brzozowski Luke,Dlamini Zodwa
Publisher
Springer Nature Switzerland
Reference121 articles.
1. Ackerstaff, E., Pflug, B. R., Nelson, J. B., & Bhujwalla, Z. M. (2001). Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Research, 61, 3599–3603.
2. Alarcón-Zendejas, A. P., Scavuzzo, A., Jiménez-Ríos, M. A., Álvarez-Gómez, R. M., Montiel-Manríquez, R., Castro-Hernández, C., Jiménez-Dávila, M. A., Pérez-Montiel, D., González-Barrios, R., & Jiménez-Trejo, F. (2022). The promising role of new molecular biomarkers in prostate cancer: From coding and non-coding genes to artificial intelligence approaches. Prostate Cancer and Prostatic Diseases, 25, 431–443.
3. Alborelli, I., Generali, D., Jermann, P., Cappelletti, M. R., Ferrero, G., Scaggiante, B., Bortul, M., Zanconati, F., Nicolet, S., & Haegele, J. (2019). Cell-free DNA analysis in healthy individuals by next-generation sequencing: A proof of concept and technical validation study. Cell Death & Disease, 10, 534.
4. Alvarez, M. M., Aizenberg, J., Analoui, M., Andrews, A. M., Bisker, G., Boyden, E. S., Kamm, R. D., Karp, J. M., Mooney, D. J., & Oklu, R. (2017). Emerging trends in micro-and nanoscale technologies in medicine: From basic discoveries to translation. ACS Nano, 11, 5195–5214.
5. Andriole, G. L., Kostakoglu, L., Chau, A., Duan, F., Mahmood, U., Mankoff, D. A., Schuster, D. M., & Siegel, B. A. (2019). The impact of positron emission tomography with 18F-fluciclovine on the treatment of biochemical recurrence of prostate cancer: Results from the LOCATE trial. The Journal of Urology, 201, 322–331.